Profiel
Ravi Kiron is the founder of C2N Diagnostics LLC, which was founded in 2007.
He held the title of Chief Business Officer from 2007 to 2008.
Dr. Kiron's current jobs include Head & BioPharma External Innovation at EMD Serono, Inc. since 2017, and Executive-in-Residence at ShangPharma Innovation, Inc. since 2017.
Dr. Kiron's former jobs include Executive Director at Johnson & Johnson from 2004 to 2007, Managing Director at Adjuvant Partners LLC from 2008 to 2011, and Global Head, Strategic Analysis & KM at Pfizer Inc. from 1991 to 2004.
He also served as Chief Business Officer at KineMed, Inc. and as a Business Development Advisor at Aduro BioTech, Inc. from 2010 to 2012.
Dr. Kiron's education includes an MBA from Rensselaer Polytechnic Institute in 1998, a doctorate from the Indian Institute of Science in 1986, and undergraduate and graduate degrees from the University of Mumbai in 1979 and 1981 respectively.
Actieve functies van Ravi Kiron
| Bedrijven | Functie | Begin |
|---|---|---|
ShangPharma Innovation, Inc.
ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation invests in companies located in the United States. The firm targets companies operating in the fields of healthcare sector. It provides financing for seed to early stage capital requirements. | Consultant / Adviseur | 01-02-2017 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Corporate Officer/Principal | 01-06-2017 |
Eerdere bekende functies van Ravi Kiron
| Bedrijven | Functie | Einde |
|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Consultant / Adviseur | 01-04-2012 |
Adjuvant Partners LLC | Corporate Officer/Principal | 01-01-2011 |
C2N Diagnostics LLC
C2N Diagnostics LLC BiotechnologyHealth Technology Operates as a protein diagnostic and therapeutic discovery company | Oprichter | 01-07-2008 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01-01-2007 |
| PFIZER INC. | Corporate Officer/Principal | 01-01-2004 |
Opleiding van Ravi Kiron
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 11 |
|---|---|
Johnson & Johnson
Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
KineMed, Inc.
KineMed, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes biomarker platform technology | Commercial Services |
Aduro BioTech, Inc.
Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company, which focuses on the development of technology platforms for cancer | Health Technology |
Rensselaer Polytechnic Institute
Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indian Institute of Science
Indian Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Mumbai
University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
C2N Diagnostics LLC
C2N Diagnostics LLC BiotechnologyHealth Technology Operates as a protein diagnostic and therapeutic discovery company | Health Technology |
ShangPharma Innovation, Inc.
ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation invests in companies located in the United States. The firm targets companies operating in the fields of healthcare sector. It provides financing for seed to early stage capital requirements. | Finance |
Adjuvant Partners LLC |
















